Comments

Krystal Biotech Stock Price, Quotes and Forecasts

Q: What sector and industry does Krystal Biotech (KRYS) operate in?

Krystal Biotech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

KRYSNASDAQ

Krystal Biotech (KRYS) Forecast

News Earnings Krystal Biotech (KRYS) Options Guidance Dividends Analyst Ratings Insider Trades Government Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Krystal Biotech Stock Price, Quotes and Forecasts | NASDAQ:KRYS | Benzinga

Explore Krystal Biotech stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for KRYS.

Open	$189.71
Close	-
Volume / Avg.	153.93K / 267.38K
Day Range	$188.80 - $195.43
52 Wk Range	141.72 - 219.34
Market Cap	$5.59B
P/E Ratio	62.36
Dividend Yield	-
Exchange	NASDAQ
RSI	67
Short Interest	12.63%
Days to Cover	7.63

Recent News

This Krystal Biotech Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

Avi Kapoor

Exelixis Gains 20.7% in Three Months: Is This the Right Time to Buy?

Shares of Exelixis, Inc. (NASDAQ: EXEL) have risen 20.7% in the past three months compared with the industry's growth of 6.3%. The stock has also outperformed the sector and the S&P 500 Index.

Zacks

IONS' Rare Neurology Disorder Candidate Gets FDA's Fast Track Tag

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) announced that the FDA has granted a Fast Track designation to its investigational RNA-targeted therapy zilganersen for treating Alexander disease (AxD), an ultra-rare neurological disorder.

Zacks

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Nov 24

Dec 24

Feb

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$189.71
Close	-
Volume / Avg.	153.93K / 267.38K
Day Range	$188.80 - $195.43
52 Wk Range	141.72 - 219.34
Market Cap	$5.59B
P/E Ratio	62.36
Dividend Yield	-
Exchange	NASDAQ
RSI	67
Short Interest	12.63%
Days to Cover	7.63

About Krystal Biotech Inc

Sector

Health Care

Industry

Biotechnology

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the d...

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

How do I buy Krystal Biotech (KRYS) stock?

You can purchase shares of Krystal Biotech (NASDAQ:KRYS) through any online brokerage.

View our list of the best stock brokerages

Who are Krystal Biotech (KRYS) competitors?

Other companies in Krystal Biotech’s space includes: Immunovant (NASDAQ:IMVT), Legend Biotech (NASDAQ:LEGN), Avidity Biosciences (NASDAQ:RNA), Ultragenyx Pharmaceutical (NASDAQ:RARE) and Sarepta Therapeutics (NASDAQ:SRPT).

What is the forecast, or price target, for Krystal Biotech (KRYS) stock?

Krystal Biotech has a consensus price target of $191.08.

What is the current price for Krystal Biotech (KRYS)?

The stock price for Krystal Biotech (NASDAQ: KRYS) is $193.9 last updated March 24, 2025 at 3:30 PM EDT.

Does Krystal Biotech (KRYS) pay a dividend?

There are no upcoming dividends for Krystal Biotech.

When is Krystal Biotech (NASDAQ:KRYS) reporting earnings?

Krystal Biotech’s Q1 earnings are confirmed for Monday, May 5, 2025.

Is Krystal Biotech (KRYS) going to split?

There is no upcoming split for Krystal Biotech.

What sector and industry does Krystal Biotech (KRYS) operate in?

Krystal Biotech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.